Fate Therapeutics
Stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
Launch date
Employees
Market cap
$425m
Enterprise valuation
$221m (Public information from Sep 2024)
Share price
$4 FATE
San Diego California (HQ)
Authorizing premium user...